Current Translational and Clinical Practices in Hematopoietic Cell and Gene Therapy

Overview

Journal Cytotherapy

Publisher Elsevier

Specialties Cell Biology
Pharmacology

Date 2012 Jul 18

PMID 22799276

Citations 3

Authors

David L DiGiusto

Hans-Peter Kiem

Affiliations

Soon will be listed here.

Abstract

Clinical trials over the last 15 years have demonstrated that cell and gene therapies for cancer, monogenic and infectious disease are feasible and can lead to long-term benefit for patients. However, these trials have been limited to proof-of-principle and were conducted on modest numbers of patients or over long periods of time. In order for these studies to move towards standard practice and commercialization, scalable technologies for the isolation, ex vivo manipulation and delivery of these cells to patients must be developed. Additionally, regulatory strategies and clinical protocols for the collection, creation and delivery of cell products must be generated. In this article we review recent progress in hematopoietic cell and gene therapy, describe some of the current issues facing the field and discuss clinical, technical and regulatory approaches used to navigate the road to product development.

Citing Articles

Lymph nodes may be a source for immunetherapy in gastric cancer.

Assumpcao P, Canelas E, Ramos A, Anaissi A, Acioli J, Ishak G Oncotarget. 2020; 11(19):1729-1736.

PMID: 32477462 PMC: 7233812. DOI: 10.18632/oncotarget.27578.

Clinical manufacturing of CAR T cells: foundation of a promising therapy.

Wang X, Riviere I Mol Ther Oncolytics. 2016; 3:16015.

PMID: 27347557 PMC: 4909095. DOI: 10.1038/mto.2016.15.

Practical considerations in gene therapy for HIV cure.

Stan R, Zaia J Curr HIV/AIDS Rep. 2014; 11(1):11-9.

PMID: 24449226 PMC: 3929767. DOI: 10.1007/s11904-013-0197-1.

References

Klebanoff C, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones A, Finkelstein S . Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A. 2005; 102(27):9571-6. PMC: 1172264. DOI: 10.1073/pnas.0503726102. View

Cooper L, Kalos M, Lewinsohn D, Riddell S, Greenberg P . Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol. 2000; 74(17):8207-12. PMC: 112357. DOI: 10.1128/jvi.74.17.8207-8212.2000. View

Urnov F, Miller J, Lee Y, Beausejour C, Rock J, Augustus S . Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature. 2005; 435(7042):646-51. DOI: 10.1038/nature03556. View

Kass R, Bellone S, Palmieri M, Cane S, Bignotti E, Henry-Tillman R . Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells. Breast Cancer Res Treat. 2003; 80(3):275-85. DOI: 10.1023/A:1024938215782. View

Gattinoni L, Klebanoff C, Palmer D, Wrzesinski C, Kerstann K, Yu Z . Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest. 2005; 115(6):1616-26. PMC: 1137001. DOI: 10.1172/JCI24480. View

Vera J, Brenner L, Gerdemann U, Ngo M, Sili U, Liu H . Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex). J Immunother. 2010; 33(3):305-15. PMC: 2946348. DOI: 10.1097/CJI.0b013e3181c0c3cb. View

Zandvliet M, van Liempt E, Jedema I, Veltrop-Duits L, Willemze R, Guchelaar H . Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Cytotherapy. 2010; 12(7):933-44. DOI: 10.3109/14653240903505822. View

Fenske D, Chonn A, Cullis P . Liposomal nanomedicines: an emerging field. Toxicol Pathol. 2008; 36(1):21-9. DOI: 10.1177/0192623307310960. View

Brunstein C, Miller J, Cao Q, McKenna D, Hippen K, Curtsinger J . Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2010; 117(3):1061-70. PMC: 3035067. DOI: 10.1182/blood-2010-07-293795. View

10.

Song D, Ye Q, Carpenito C, Poussin M, Wang L, Ji C . In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB). Cancer Res. 2011; 71(13):4617-27. PMC: 4140173. DOI: 10.1158/0008-5472.CAN-11-0422. View

11.

Peggs K, Verfuerth S, Pizzey A, Khan N, Guiver M, Moss P . Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet. 2003; 362(9393):1375-7. DOI: 10.1016/S0140-6736(03)14634-X. View

12.

Spanholtz J, Preijers F, Tordoir M, Trilsbeek C, Paardekooper J, de Witte T . Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process. PLoS One. 2011; 6(6):e20740. PMC: 3116834. DOI: 10.1371/journal.pone.0020740. View

13.

Gattinoni L, Finkelstein S, Klebanoff C, Antony P, Palmer D, Spiess P . Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. J Exp Med. 2005; 202(7):907-12. PMC: 1397916. DOI: 10.1084/jem.20050732. View

14.

Hacein-Bey-Abina S, Garrigue A, Wang G, Soulier J, Lim A, Morillon E . Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008; 118(9):3132-42. PMC: 2496963. DOI: 10.1172/JCI35700. View

15.

Kochenderfer J, Feldman S, Zhao Y, Xu H, Black M, Morgan R . Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor. J Immunother. 2009; 32(7):689-702. PMC: 2747302. DOI: 10.1097/CJI.0b013e3181ac6138. View

16.

Heslop H, Slobod K, Pule M, Hale G, Rousseau A, Smith C . Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2009; 115(5):925-35. PMC: 2817637. DOI: 10.1182/blood-2009-08-239186. View

17.

Gajewski T, Meng Y, Blank C, Brown I, Kacha A, Kline J . Immune resistance orchestrated by the tumor microenvironment. Immunol Rev. 2006; 213:131-45. DOI: 10.1111/j.1600-065X.2006.00442.x. View

18.

Greenberg P, Goodrich J, Riddell S . Adoptive immunotherapy of human cytomegalovirus infection: potential role in protection from disease progression. Transplant Proc. 1991; 23(3 Suppl 3):97-101. View

19.

Hosseinkhani H, Tabata Y . Self assembly of DNA nanoparticles with polycations for the delivery of genetic materials into cells. J Nanosci Nanotechnol. 2006; 6(8):2320-8. DOI: 10.1166/jnn.2006.507. View

20.

Pruett-Miller S, Reading D, Porter S, Porteus M . Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet. 2009; 5(2):e1000376. PMC: 2633050. DOI: 10.1371/journal.pgen.1000376. View